An R21 from the National Institutes of Health will help assistant professor Ophelia Venturelli and her co-investigator Daniel Amador-Noguez, an associate professor of bacteriology, tease apart the microbial interactions and metabolites impacting C. difficile growth. F
Read the full article at: https://biochem.wisc.edu/news/2021/news-venturelli-r21-advance-personalized-microbiome-therapies-2021-09-21